It is currently Mon Dec 09, 2013 10:55 pm
Early intervention with atorvastatin in patients with CIS will result in a state of immunological tolerance.
19 January 2005 Vernalis Plc: Anti-Inflammatory Compound Partnered with Serono Starts Clinical Trials Vernalis plc (LSE:VER, Nasdaq: VNLS), today announced that its partner Serono (virt-x: SEO and NYSE: SRA) has started a phase I clinical trial of a selective inhibitor of MMP-12 (matrix metalloprotease inhibitor-12). This is the first compound to enter the clinic resulting from ...
Total posts 211467 • Total topics 21491 • Total members 13455